Novartis Oncology sinking.







Failed studies. Weak leadership and lots of inbreeding. What's going on?

When the development team took their private tour in the Vatican last year, they obviously didn't leave enough of an offering. Maybe the almighty is displeased.

Seriously, I think it's great that an Italian head of development takes his time to Rome in 2010 and Venice in 2011. Great use of company resource. Great job. Let Gen meds cut costs and let oncology ride gondolas for their team building in Venice